Engineered inorganic nanoparticles for drug delivery applications.

Area of Science:

• Biomedical Engineering
• Materials Science
• Nanotechnology

Background:

• Inorganic nanoparticles (NPs) possess unique physicochemical properties, including high surface area and functionalizability, making them promising for drug delivery.
• The combination of NPs with drugs (NP-drug conjugates) presents an attractive alternative for enhanced therapeutic strategies.
• Local drug delivery via NPs can minimize systemic side effects and improve drug efficacy.

Purpose of the Study:

• To review the implications of inorganic nanoparticles in developing advanced drug delivery systems.
• To highlight the specific applications of inorganic NPs in targeted cancer therapies.
• To underscore the growing importance of understanding nanoparticle toxicity for human safety.

Main Methods:

• Literature review focusing on inorganic nanoparticles in drug delivery.
• Analysis of NP properties relevant to drug vectorization.
• Examination of studies on NP-drug conjugates and their therapeutic applications.
• Assessment of research concerning nanoparticle safety and toxicity.

Main Results:

• Inorganic NPs demonstrate significant potential as drug delivery vectors due to their tunable properties.
• NP-drug conjugates enable targeted delivery, improving treatment outcomes, particularly in oncology.
• The expanding use of NPs necessitates a comprehensive understanding of their potential human health risks.

Conclusions:

• Inorganic nanoparticles are pivotal in advancing drug delivery systems, offering targeted and efficient therapeutic options.
• Targeted cancer therapies are a key area benefiting from inorganic NP applications.
• Prioritizing safety assessments and toxicity studies is essential for the responsible development and deployment of nanoparticle-based technologies.